FRM
Fox Run Management’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $474K | Buy |
+27,706
| New | +$474K | 0.08% | 486 |
|
|
2024
Q2 | – | Sell |
-6,801
| Closed | -$880K | – | 1063 |
|
|
2024
Q1 | $880K | Sell |
6,801
-2,732
| -29% | -$354K | 0.19% | 169 |
|
|
2023
Q4 | $919K | Buy |
+9,533
| New | +$919K | 0.23% | 108 |
|
|
2022
Q3 | – | Sell |
-7,626
| Closed | -$572K | – | 814 |
|
|
2022
Q2 | $572K | Buy |
7,626
+341
| +5% | +$25.6K | 0.29% | 96 |
|
|
2022
Q1 | $569K | Buy |
+7,285
| New | +$569K | 0.32% | 69 |
|
|
2021
Q2 | – | Sell |
-4,902
| Closed | -$365K | – | 436 |
|
|
2021
Q1 | $365K | Buy |
+4,902
| New | +$365K | 0.66% | 36 |
|
|
2019
Q2 | – | Sell |
-1,986
| Closed | -$237K | – | 614 |
|
|
2019
Q1 | $237K | Buy |
+1,986
| New | +$237K | 0.13% | 347 |
|
|
2018
Q4 | – | Sell |
-3,117
| Closed | -$503K | – | 707 |
|
|
2018
Q3 | $503K | Buy |
+3,117
| New | +$503K | 0.22% | 171 |
|
|
2017
Q4 | – | Sell |
-4,500
| Closed | -$204K | – | 876 |
|
|
2017
Q3 | $204K | Buy |
+4,500
| New | +$204K | 0.06% | 604 |
|
|
2017
Q2 | – | Sell |
-13,100
| Closed | -$388K | – | 820 |
|
|
2017
Q1 | $388K | Buy |
+13,100
| New | +$388K | 0.16% | 269 |
|